ES2099206T3 - Derivados de benceno que favorecen la produccion del factor de crecimiento de los nervios humanos. - Google Patents

Derivados de benceno que favorecen la produccion del factor de crecimiento de los nervios humanos.

Info

Publication number
ES2099206T3
ES2099206T3 ES92301326T ES92301326T ES2099206T3 ES 2099206 T3 ES2099206 T3 ES 2099206T3 ES 92301326 T ES92301326 T ES 92301326T ES 92301326 T ES92301326 T ES 92301326T ES 2099206 T3 ES2099206 T3 ES 2099206T3
Authority
ES
Spain
Prior art keywords
group
amino group
substituted
growth factor
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92301326T
Other languages
English (en)
Inventor
Shunji Naruto
Yuichi Sugano
Keiichi Matsuda
Masahiko Sugimoto
Tomiichiro Oda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2099206T3 publication Critical patent/ES2099206T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)

Abstract

SE PROPORCIONAN LOS NUEVOS DERIVADOS DEL BENCENO DE LA FORMULA GENERAL (I) : [ DONDE R ELEVADO 1 REPRESENTA UN GRUPO AMINO, UN GRUPO AMINO SUSTITUIDO, UN GRUPO AMINO PROTEGIDO O UN GRUPO NITRO; R (AL CUADRADO) REPRESENTA UN GRUPO AMINO, UN GRUPO AMINO SUSTITUIDO, UN GRUPO AMINO PROTEGIDO, UN GRUPO HIDROXILO, UN GRUPO HIDROXILO SUSTITUIDO O UN GRUPO HIDROXILO PROTEGIDO; R ELEVADO 3 REPRESENTA UN GRUPO AMINO, UN GRUPO AMINO SUSTITUIDO, UN GRUPO HETEROCICLICO PROVISTO DE UN ATOMO DE ANILLO DE NITROGENO COMO EL PUNTO DE UNION, O UN GRUPO HETEROCICLICO SUSTITUIDO PROVISTO DE UN ATOMO DE ANILLO DE NITROGENO COMO EL PUNTO DE UNION; M ES DE 0 A 2; N ES DE 0 A 6; CON LA CONDICION DE QUE CUANDO M SEA 0, ENTONCES N REPRESENTARA UN ENTERO DE 2 A 6] Y LAS SALES DEL MISMO. COMPUESTOS DE LA FORMULA (I) EXCEPTO AQUELLOS DONDE R ELEVADO 1 ES UN GRUPO NITRO PROVISTO DE ACTIVIDAD PARA PROMOVER LA PRODUCCION DEL FACTOR DE CRECIMIENTO DE LOS NERVIOS. COMPUESTOS DE LA FORMULA (I) DONDE R ELEVADO 1 ES UN GRUPO NITRO SON INTERMEDIARIOS PARA LOS COMPUESTOS DE LA FORMULA (I) DONDE R ELEVADO 1 ES UN GRUPO AMINO.
ES92301326T 1991-02-21 1992-02-18 Derivados de benceno que favorecen la produccion del factor de crecimiento de los nervios humanos. Expired - Lifetime ES2099206T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2706091 1991-02-21

Publications (1)

Publication Number Publication Date
ES2099206T3 true ES2099206T3 (es) 1997-05-16

Family

ID=12210527

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92301326T Expired - Lifetime ES2099206T3 (es) 1991-02-21 1992-02-18 Derivados de benceno que favorecen la produccion del factor de crecimiento de los nervios humanos.

Country Status (16)

Country Link
US (2) US5643925A (es)
EP (1) EP0501656B1 (es)
JP (1) JPH05112515A (es)
KR (1) KR920016406A (es)
CN (1) CN1036064C (es)
AT (1) ATE148098T1 (es)
CA (1) CA2061557A1 (es)
CZ (1) CZ50092A3 (es)
DE (1) DE69216873T2 (es)
DK (1) DK0501656T3 (es)
ES (1) ES2099206T3 (es)
GR (1) GR3022594T3 (es)
HK (1) HK1005722A1 (es)
HU (1) HUT64012A (es)
IE (1) IE920538A1 (es)
RU (1) RU2042663C1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
GB2349880A (en) * 1999-05-10 2000-11-15 Secr Defence (Thio)morpholinium salts having SHG activity
US6348648B1 (en) 1999-11-23 2002-02-19 Harry Connick, Jr. System and method for coordinating music display among players in an orchestra
KR20020089440A (ko) * 2000-04-11 2002-11-29 다카라 바이오 가부시키가이샤 치료제
DE10115994A1 (de) * 2001-03-30 2002-10-10 Wella Ag (p-Amino-hydroxyphenyl)acrylamid-Derivate und diese Verbindungen enthaltende Färbemittel
MXPA04005427A (es) * 2001-12-10 2005-04-19 Amgen Inc Ligandos de receptor vainilloide y su uso en tratamientos.
KR100459917B1 (ko) * 2001-12-14 2004-12-03 (주)바이오뉴트리젠 페놀릭산 유도체 및 이를 포함하는 혈중 지질 농도 관련질환의 예방 및 치료용 조성물
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
SE0302139D0 (sv) * 2003-07-28 2003-07-28 Astrazeneca Ab Novel compounds
JP2006008642A (ja) * 2004-06-29 2006-01-12 Sumitomo Bakelite Co Ltd アミノフェノール化合物、熱硬化性化合物およびその製造法
CA2594860A1 (en) * 2005-01-14 2006-07-20 Millennium Pharmaceuticals, Inc. Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
US8158828B2 (en) 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
US9409856B2 (en) 2005-11-28 2016-08-09 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US8637706B2 (en) 2005-11-28 2014-01-28 Gtx, Inc. Nuclear receptor binding agents
US8546451B2 (en) 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
ES2388454T3 (es) 2007-03-22 2012-10-15 Astrazeneca Ab Derivados de quinolina para el tratamiento de enfermedades inflamatorias
PE20091036A1 (es) 2007-11-30 2009-08-15 Astrazeneca Ab Derivado de quinolina como antagonista del receptor p2x7
US9427418B2 (en) 2009-02-23 2016-08-30 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US9624161B2 (en) 2009-02-23 2017-04-18 Gtx, Inc. Estrogen receptor ligands and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147261A (en) * 1962-05-24 1964-09-01 Robert R Mod Nu-acyl-nu'-methylpiperazines
GB1052308A (es) * 1964-08-25
GB8417194D0 (en) * 1984-07-05 1984-08-08 Boots Co Plc Therapeutic agents
NZ228329A (en) * 1988-03-18 1991-12-23 Mitsui Toatsu Chemicals Catechol derivatives and pharmaceutical compositions thereof
JPH02104568A (ja) * 1988-06-22 1990-04-17 Yoshitomi Pharmaceut Ind Ltd 神経成長因子産生促進作用剤
DD299424A5 (de) * 1989-05-23 1992-04-16 Sankyo Company Limited,Jp Phenolderivate zur foerderung des menschlichen nervenwachstumsfaktors
JP2761048B2 (ja) * 1989-08-25 1998-06-04 三共株式会社 神経成長因子産生促進剤

Also Published As

Publication number Publication date
HU9200579D0 (en) 1992-05-28
ATE148098T1 (de) 1997-02-15
DE69216873T2 (de) 1997-08-21
HK1005722A1 (en) 1999-01-22
IE920538A1 (en) 1992-08-26
KR920016406A (ko) 1992-09-24
GR3022594T3 (en) 1997-05-31
DE69216873D1 (de) 1997-03-06
CN1036064C (zh) 1997-10-08
RU2042663C1 (ru) 1995-08-27
CA2061557A1 (en) 1992-08-22
EP0501656A3 (en) 1993-03-03
CZ50092A3 (en) 1993-03-17
CN1064273A (zh) 1992-09-09
JPH05112515A (ja) 1993-05-07
EP0501656A2 (en) 1992-09-02
EP0501656B1 (en) 1997-01-22
US5643925A (en) 1997-07-01
HUT64012A (en) 1993-11-29
US5614521A (en) 1997-03-25
DK0501656T3 (da) 1997-07-21

Similar Documents

Publication Publication Date Title
ES2099206T3 (es) Derivados de benceno que favorecen la produccion del factor de crecimiento de los nervios humanos.
DK602589A (da) Quinazolinonderivater
DE3851179D1 (de) Oxetanocin.
DE69428142D1 (de) Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
MX9206093A (es) Derivado de oxazolidona
ES551522A0 (es) Procedimiento para preparar 5h, 11h-pirrolo-2,1-c-1,4 benzoxazepinas sustituidas en posicion 11
DE3586649D1 (de) Verwendung von spergualinderivaten zur herstellung von arzneimitteln mit immunodepressiver wirkung.
ES8604604A1 (es) Un procedimiento para la produccion de 3,3",4"-tri-o-acilespiramicina i"-.
ATE152708T1 (de) (1,2n) und (3,2n)-karbozyklische-2-amino- tetralinderivate
DE69423339D1 (de) Epoxycyclohexendionderivat
FI860074A (fi) Oktahydroindolizinfoereningar anvaendbara som smaertstillande medel.
PT90302A (pt) Processo para a preparacao de derivados de lactamas hetero-tetraciclicas
ES537805A0 (es) Un derivado de acetileno
MY104689A (en) Amine salts of 1,4,2-oxazaphospholidine-4-acetic acid, 2-alkoxy-2-oxides.
AU7637591A (en) Cis and trans stilbenes and their compositions for the treatment of hypertension
ATE79259T1 (de) Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung.
ES2045335T3 (es) Un procedimiento para la preparacion de nuevas s-difluorometilhomocisteinas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 501656

Country of ref document: ES